Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis

被引:75
|
作者
Ward, MM
机构
[1] VA Palo Alto Hlth Care Syst 111G, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA
关键词
lupus nephritis; renal transplantation; end-stage renal disease; USRDS;
D O I
10.1046/j.1523-1755.2000.00065.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Although the outcomes of renal transplantation among patients with end-stage renal disease (ESRD) caused by lupus nephritis have generally been found to be comparable to those of patients with other causes of ESRD, some studies indicate that cadaveric graft failure is more common among these patients. However, most previous studies examined small numbers of patients and did not adjust for important confounding factors. Methods. Graft failure and patient mortality after the first cadaveric renal transplantation were compared between 772 adults with ESRD caused by lupus nephritis and 32,644 adults with ESRD caused by other causes who received a transplant between 1987 and 1994 and were included in the United States Renal Data System. The median follow-up times were 4.9 and 5.0 years in the two groups, respectively. Multivariate Cox regression models were used to adjust the risks of graft failure and mortality for group differences in recipient and donor characteristics. Similar comparisons were performed between 390 adults with ESRD caused by lupus nephritis and 10,512 adults with ESRD caused by other causes after first living-related renal transplantation. Results. In an unadjusted analysis, the risk of graft failure after first cadaveric transplant was slightly but significantly greater among patients with ESRD caused by lupus nephritis than among those with ESRD caused by other causes [hazard ratio (HR), 1.13; 95% CI, 1.01 to 1.26, P = 0.04]. However, after adjustment for potential confounding factors, the risk of graft failure was not increased in patients with ESRD caused by lupus nephritis (HR, 1.08; 95% CI, 0.94 to 1.23, P = 0.28). Mortality after the first cadaveric transplantation did not differ between groups. The adjusted risks of graft failure (HR, 1.06; 95% CI, 0.84 to 1.32, P = 0.62) and patient mortality (HR = 0.69; 95% CI, 0.45 to 1.05, P = 0.09) after the first living-related renal transplant were also not significantly higher among patients with ESRD caused by lupus nephritis. Conclusions. Graft and patient survival after first cadaveric and first living-related renal transplants are similar in patients with ESRD caused by lupus nephritis and patients with ESRD from other causes.
引用
收藏
页码:2136 / 2143
页数:8
相关论文
共 50 条
  • [11] Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
    Koopman, Jacob J. E.
    Rennke, Helmut G.
    Leatherwood, Cianna
    Speyer, Cameron B.
    D'Silva, Kristin
    McMahon, Gearoid M.
    Waikar, Sushrut S.
    Costenbader, Karen H.
    RHEUMATOLOGY, 2020, 59 (12) : 3751 - 3758
  • [12] Familial clustering of end-stage renal disease in blacks with lupus nephritis
    Freedman, BI
    Wilson, CH
    Spray, BJ
    Tuttle, AB
    Olorenshaw, IM
    Kammer, GM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (05) : 729 - 732
  • [13] SURVIVAL PATTERNS IN LUPUS NEPHRITIS WITH END-STAGE RENAL-DISEASE
    WADHWA, NK
    KANT, KS
    CLYNE, DH
    FIRST, MR
    POLLAK, VE
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 212 - 212
  • [14] Factors affecting transplant outcomes inpatients with end stage renal disease caused by Lupus Nephritis
    Bunnapradist, S
    Peng, A
    Chung, P
    Hong, A
    Chung, P
    Lee, B
    Fukami, S
    Takemoto, SK
    Singh, AK
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 520 - 520
  • [15] Sex Differences in Rates of End-Stage Renal Disease and Death Among Medicaid Patients with Incident Lupus Nephritis
    Broder, Anna R.
    Feldman, Candace H.
    Kumthekar, Anand
    Alevizos, Michail
    Guan, Hongshu
    Barbhaiya, Medha
    Costenbader, Karen H.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [16] Outcomes of Dialysis Among Patients With End-Stage Renal Disease (ESRD)
    Ejaz, Ayesha
    Junejo, Abdul Manan
    Ali, Muhammad
    Ashfaq, Ahsan
    Hafeez, Abdul Rauf
    Khan, Sadaqat Ali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [17] The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis
    Koo, H. S.
    Kim, Y. C.
    Lee, S. W.
    Kim, D. K.
    Oh, K-H
    Joo, K. W.
    Kim, Y. S.
    Ahn, C.
    Han, J. S.
    Kim, S.
    Chin, H. J.
    LUPUS, 2011, 20 (13) : 1442 - 1449
  • [18] Methodological quality of studies of end-stage renal disease risks in lupus nephritis
    Tektonidou, Maria
    Dasgupta, Abhijit
    Ward, Michael
    ARTHRITIS RESEARCH & THERAPY, 2014, 16
  • [19] Methodological quality of studies of end-stage renal disease risks in lupus nephritis
    Maria Tektonidou
    Abhijit Dasgupta
    Michael Ward
    Arthritis Research & Therapy, 16
  • [20] Renal transplantation in sickle cell disease patients with end-stage renal disease
    Abreo, K
    Zibari, G
    Sella, M
    Roggero, T
    McDonald, J
    TRANSPLANTATION, 1999, 67 (09) : S617 - S617